INFORMED.
LIVE

Advanced Enzyme Technologies Limited

BSE: ADVENZYMES540025ISIN INE837H01020
  • Healthcare
  • Biotechnology
  • BSE 1000

Share price

₹288.15+0.15 (+0.05%)
as of 18 Sep 2026
Advanced Enzyme Technologies Limited share price, 18 Sep 2025 to 18 Sep 2026: ₹340.00 to ₹288.15 (-15.3%). Low ₹265.35, high ₹391.35. Volume shown below the price.
52W high
₹419.80
52W low
₹251.90
Off 52W high
-31.36%
1M return
-5.62%
3M return
-22.78%
6M return
+5.76%
1Y return
-15.25%
20D avg volume
8,948
50 DMA
₹307.42
200 DMA
₹314.05

Key ratios Consolidated

Market cap
₹3,227 Cr
Current price
₹288.15
52W high / low
₹419.80 / ₹251.90
Face value
₹2.00
P/E
18.79
P/B
EPS (TTM)
₹15.34
Book value / share
ROE
ROCE
13.60%
Operating margin
Net margin
Debt / equity
0.01
Net debt
₹-88.22 Cr
Interest cover
89.42
Dividend yield
0.47%
Dividend / share (TTM)
₹1.35
Payout
8.80%
Cash conversion cycle
138.2 days

Financials

MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
189.79203.37171.95184.53185.91167.18
13.027.238.4710.288.858.74
149.28150.90133.37135.27139.86132.46
54.5055.9645.6448.7443.9745.94
0.000.000.000.000.000.00
44.5541.9441.2639.3739.7136.84
0.580.570.570.720.760.81
9.8810.1910.2110.089.6210.08
44.5841.2739.9340.5339.7238.65
53.5359.6947.0559.5454.9043.46
0.000.1111.250.000.000.00
53.5359.8058.2959.5454.9043.46
14.9414.5515.1114.8114.4616.73
38.5945.2543.1844.7340.4426.73
3.313.843.803.873.572.37
Key metrics
63.9970.5669.0770.3465.2854.35
33.70%34.70%40.20%38.10%35.10%32.50%
20.30%22.30%25.10%24.20%21.80%16.00%
3.50%3.80%2.90%
2.10%21.60%
-4.60%69.30%
MetricTTMFY26FY25FY24
Income statement
749.64745.76636.91
39.0034.8333.04
568.82559.41482.59
204.84194.31161.96
0.000.000.00
167.12162.29141.54
2.442.633.56
40.3640.0936.56
166.31161.45149.07
219.81221.18187.36
11.3611.360.00
231.16232.54187.36
59.4158.9353.39
171.75173.61133.97
14.8215.0811.72
Key metrics
273.96275.26227.48
36.55%36.90%35.70%
22.91%23.30%21.00%
13.60%12.50%
17.10%
29.60%
104.55108.69
0.901.06
0.010.01
-88.22-72.69
138.2146.4
Balance sheet
1,8391,621
1,044879.87
108.7594.22
145.02115.40
177.28157.31
11.07
275.83292.94
39.9617.20
106.7296.75
20.5321.53
12.6412.35
7.899.18
1,6831,469
Cash flow
156.78142.50
-74.13-89.10
-70.37-72.54
52.2333.81
MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
115.86116.4195.58115.75125.0287.21
2.295.161.293.0853.854.53
88.4092.7375.2089.2197.4876.23
48.0950.1337.3648.3251.9037.79
0.000.000.000.000.000.00
17.6916.3616.1016.0616.2114.56
0.040.060.040.050.050.08
2.923.123.043.002.933.11
26.1624.5922.3024.0422.0420.29
29.7428.8421.6729.6281.4015.51
0.000.00-3.860.000.000.00
29.7428.8417.8229.6281.4015.51
7.396.554.577.347.424.46
22.3522.3013.2522.2873.9811.05
2.001.991.181.996.610.99
Key metrics
32.7032.0220.9032.6784.3818.70
28.20%27.50%21.90%28.20%67.50%21.40%
19.30%19.20%13.90%19.20%59.20%12.70%
4.00%4.30%2.40%
-7.30%33.50%
-69.80%101.80%
MetricTTMFY26FY25FY24
Income statement
443.60452.77351.41
11.8263.3961.49
345.54354.62292.37
183.90187.72148.80
0.000.000.00
66.2164.7356.03
0.190.210.24
12.0812.0811.40
97.0992.9782.36
109.87161.53120.53
-3.86-3.860.00
106.02157.67120.53
25.8525.8718.11
80.18131.81102.42
7.1611.789.16
Key metrics
118.29169.96132.17
26.67%37.50%37.60%
18.07%29.10%29.10%
21.80%18.80%
28.80%
28.70%
44.4941.14
0.670.62
0.000.00
-1.89-5.60
128.6163.0
Balance sheet
803.64688.63
315.98232.20
1.895.60
94.3278.17
116.52101.45
5.385.19
145.47150.88
51.1922.68
77.8444.70
0.000.00
0.000.00
0.000.00
709.62629.34
Cash flow
88.7363.48
-34.19-1.74
-58.25-57.63
44.2422.34

Compounded growth

Standalone

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Consolidated

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding
43.24%
HolderTypeHoldingPreviousChange
Vasant RathiPromoter26.68%
Orbimed Asia III Mauritius FVCI LimitedPublic12.06%
Nalanda India Equity Fund LimitedPublic8.45%
Vasant and Prabha Rathi Generation TrustPromoter Group6.70%
Polunin Emerging Markets Small Cap Fund, LLCPublic2.46%
Rasika Vasant RathiPromoter Group2.38%
Reshma Namita RathiPromoter Group2.36%
Rachana Vasant RathiPromoter Group2.36%
Clarus Capital IPublic2.28%
Marval Guru FundPublic1.79%
Pradip Bhailal ShahPublic1.66%
Mukund Madhusudan KabraPublic1.63%
Kishor Laxminarayan Rathi HUFPromoter Group0.98%
Prabhavati Vasant RathiPromoter Group0.82%
Madhusudan KabraPromoter Group0.55%

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Corporate actions

PurposeEx dateRecord datePayment date
Dividend - Rs. - 1.350024 Jul 202624 Jul 2026
Final Dividend - Rs. - 1.200023 Jul 202523 Jul 2025
Interim Dividend - Rs. - 4.000016 May 202517 May 2025
Final Dividend - Rs. - 1.100018 Jul 202418 Jul 2024

Board meetings

  • Board Meeting - Financial Results